A network meta-analysis on the efficacy of different mycotoxin binders to reduce aflatoxin M1 in milk after aflatoxin B1 challenge in dairy cows.

The objective of this network meta-analysis was to determine the efficacy of different mycotoxin binders (MTB) to reduce aflatoxin M1 (AFM1) in milk. A literature search was conducted to identify in vivo research papers from different databases. Inclusion criteria were in vivo, dairy cows, description of the MTB used, doses of MTB, aflatoxin inclusion in the diet, and concentration of AFM1 in milk. Twenty-eight papers with 131 data points were selected. Binders used in the studies were hydrated sodium calcium aluminosilicate (HSCAS), yeast cell wall (YCW), bentonite, and mixes of several MTB (MX). The response variables were AFM1 concentration, AFM1 reduction in milk, total AFM1 excreted in milk, and transfer of aflatoxin from feed to AFM1 in milk. Data were analyzed with CINeMA and GLIMMIX procedures with the WEIGHT statement of SAS (SAS Inst. Inc.). The AFM1 concentration in milk decreased for bentonite (0.3 µg/L ± 0.05; mean ± SE) and HSCAS (0.4 µg/L ± 0.12), and tended to decrease for MX (0.6 µg/L ± 0.13) but was similar for YCW (0.6 µg/L ± 0.12), compared with control (0.7 µg/L ± 0.12). The percentage reduction of AFM1 in milk was similar for all MTB and different from control with a range of reduction from 25% for YCW to 40% for bentonite. The excretion of AFM1 in milk was lower in YCW (5.3 µg/L ± 2.37), HSCAS (13.8 µg/L ± 3.31), and MX (17.1 µg/L ± 5.64), and not affected by bentonite (16.8 µg/L ± 3.33) compared with control (22.1 µg/L ± 5.33). The transfer of aflatoxin B1 from feed into AFM1 in milk was lowest in bentonite (0.6% ± 0.12), MX (1.04% ± 0.27), and HSCAS (1.04% ± 0.21), and not affected in YCW (1.4% ± 0.10), compared with control (1.7% ± 0.35). The meta-analysis results indicate that all MTB reduced the AFM1 transfer into milk, where bentonite had the highest capacity and YCW the lowest.

Relative bioavailability of 3 rumen-undegradable methionine sources in dairy cows using the area under the curve technique.

The objective of this study was to evaluate the relative bioavailability of two 2-hydroxy-4-(methylthio)butanoic isopropyl esters (HMBi) obtained through different production processes and an encapsulated rumen-protected Met using the area under the curve (AUC) method. The new HMBi product (Kessent MF Liquid, Kemin Animal Nutrition and Health) was compared with an existing HMBi product (Metasmart, Adisseo SAS) and a pH-sensitive coated Met (Smartamine, Adisseo SAS). Nine multiparous lactating cows (30 kg of milk/d and 227 d in milk) fed a 45:55 forage:concentrate diet were randomly assigned within square to a triplicate 3 × 3 Latin square design. Each period consisted of a 3-d sampling period and a 3-d washout period. Treatments were dosed on d 1 of each period, and blood samples were collected from the coccygeal vein at 0, 1, 2, 3, 4, 6, 9, 12, 24, 30, and 48 h thereafter. The daily dose was 50 g of Met equivalent of each treatment. The HMBi treatments were administered directly into the cow's mouth, whereas Smartamine was fed mixed with 0.5 kg of concentrate and fully consumed within 15 min. Nonlinear models were fitted to raw data, and the basal concentration at time 0 h, time at peak (Tmax), concentration at peak, and AUC of plasma Met were determined. The Met basal concentration at t = 0 h (26.7 ± 7.67 µM) and concentration at peak (210 ± 22.2 µM) were similar among treatments, but the Tmax (11.3 vs. 1.4 h) was delayed and the AUC was 1.8-fold larger (3,457 vs. 1,868 arbitrary units) in Smartamine compared with HMBi. Results of this study indicate that the 2 HMBi products have similar plasma kinetics and bioavailability. Smartamine had different kinetics compared with HMBi products, with delayed Tmax and larger AUC and relative bioavailability.

In vitro assessment of the capacity of certain mycotoxin binders to adsorb some amino acids and water-soluble vitamins.

The objective of this study was to evaluate the capacity of 6 mycotoxin binders (MTB) to adsorb 3 AA and 4 water-soluble vitamins (WSV). Two experiments were conducted in in vitro conditions to simulate postruminal digestion with pepsin, malic acid, citric acid, acetic acid, and lactic acid at pH 3.0 and intestinal digestion with bile salts and pancreatin extract at pH 6.5. Experiment 1 was conducted with AA, and experiment 2 was conducted with WSV. Within experiment, main factors were the MTB (bentonite, clinoptiolite, sepiolite, montmorillonite, activated carbon, and yeast cell walls), the substrate (AA: Lys, Met, and Thr; WSV: B1, B2, B3, and B6), and the incubation strategy (substrates alone or mixed). Data were analyzed for the effects of main factors and their interactions. In experiment 1, the adsorption average for AA when incubated separately was 44.3%, ranging from 62.4% for Thr by clinoptiolite to 20.0% for Thr by activated carbon. When incubated together, the average adsorption was reduced to 19.9%, suggesting competition among substrates for adsorption. Adsorption ranged from 29.8% for Thr by yeast cell walls to 5.6% for Met by clinoptiolite, but there were significant interactions among MTB and AA. In experiment 2, the average adsorption of WSV when incubated separately or together was 34.1 and 45.1%, respectively, suggesting possible synergies among substrates. When vitamins were incubated separately, adsorption ranged from 90.5% for vitamin B1 to 4.0% for vitamin B3 by montmorillonite. Vitamins B1 (except by yeast cell walls) and B6 (except by bentonite, sepiolite, and montmorillonite) were absorbed the most, and vitamin B3 was absorbed the least (except by activated carbon and yeast cell walls, which were least together with vitamin B2). When vitamins were incubated together, adsorption ranged from 97.0% for vitamin B1 by montmorillonite to 0% for vitamin B2 by activated carbon and vitamin B3 by bentonite. Vitamins B1 by all MTB and B6 by clinoptiolite, sepiolite, and yeast cell walls were the most adsorbed, and vitamin B3 (except by activated carbon and yeast cell wall) was the least absorbed. There were significant interactions among MTB and WSV. Mycotoxin binders have a high degree of adsorption of the AA and WSV tested in in vitro conditions, which may limit their bioavailability. Results also suggest that when substrates were incubated together some interactions for adsorption occurred, which were competitive among AA and synergic among vitamins.